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Neutrophilic inflammation is central to disease pathogenesis, for example, in chronic obstructive pulmonary disease, yet
the mechanisms that retain neutrophils within tissues remain poorly understood. With emerging evidence that axon
guidance factors can regulate myeloid recruitment and that neutrophils can regulate expression of a class 3 semaphorin,
SEMA3F, we investigated the role of SEMA3F in inflammatory cell retention within inflamed tissues. We observed that
neutrophils upregulate SEMA3F in response to proinflammatory mediators and following neutrophil recruitment to the
inflamed lung. In both zebrafish tail injury and murine acute lung injury models of neutrophilic inflammation,
overexpression of SEMA3F delayed inflammation resolution with slower neutrophil migratory speeds and retention of
neutrophils within the tissues. Conversely, constitutive loss of sema3f accelerated egress of neutrophils from the tail injury
site in fish, whereas neutrophil-specific deletion of Sema3f in mice resulted in more rapid neutrophil transit through the
airways, and significantly reduced time to resolution of the neutrophilic response. Study of filamentous-actin (F-actin)
subsequently showed that SEMA3F-mediated retention is associated with F-actin disassembly. In conclusion, SEMA3F
signaling actively regulates neutrophil retention within the injured tissues with consequences for neutrophil clearance and
inflammation resolution.
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Introduction
Effective host responses to injury and infection require both rapid 
recruitment of neutrophils into tissues and timely inflammation res-
olution. Research efforts have focused separately on the initiation 
and resolution phases of inflammation and, in terms of resolution, 
on how neutrophil survival responses determine the duration and 
extent of the inflammatory response (1). Less focus has been placed 
on mechanisms by which viable neutrophils may be retained within 
the inflammatory site and thus contribute to the ongoing inflamma-
tion, yet this may be of particular therapeutic importance given the 
dominance of viable neutrophil numbers in inflamed tissue, even 
during the resolution phase of the innate immune response.
Directed neutrophil migration, essential for neutrophil recruit-
ment to the injury site and an effective innate immune response, 
is critically dependent upon polarization of the cell. Cell polarity 
is tightly regulated by phosphoinositide 3-kinase (PI3K) signaling 
products, with PI3K activation at the leading edge linked to micro-
tubule assembly and activation of key regulators of the actin cyto-
skeleton, including Rho and Rac (2–4). These pathways are, unsur-
prisingly, well conserved across cell populations in which directed 
migration of cells is also of critical importance, for instance, axonal 
migration or angiogenesis (5–7). Less is known about the mecha-
nisms that regulate neutrophil speed of migration to, and mainte-
nance at, the site of tissue injury. Given the parallels to directed 
migration in other systems, we asked whether proteins previously 
shown to regulate either axon repulsion or attraction and display-
ing regulated expression in immune cells may be important in sig-
naling neutrophil retention within inflamed tissues and thus have 
an impact on inflammation resolution.
In previous studies of neutrophil hypoxic responses (8), we 
observed that one of the genes most highly regulated by the pro-
lyl hydroxylase domain–containing enzyme PHD3 was Sema3f, 
a member of the semaphorin family of secreted and transmem-
brane axon guidance molecules (9). Semaphorins, originally 
identified as chemorepulsive molecules for axonal growth cones, 
have since been implicated in regulating cell motility in the con-
text of vascular growth and tumor progression, and in immune 
signaling and immune synapse formation (10–12). More recently, 
the class 3 semaphorin SEMA3A was shown to act as an attrac-
tant for tumor-associated macrophages (TAMs), regulating their 
localization and retention within hypoxic tumor areas (13). This 
led us to question whether SEMA3F might also play a critical role 
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down of sema3fa or sema3fb alone or in combination using both 
translation- and splice-blocking MOs had no effect on neutrophil 
recruitment (Figure 2, A and B, and Supplemental Figure 2B), dis-
ruption of either sema3fa or sema3fb resulted in dramatically accel-
erated inflammation resolution. Either sema3fa MO or sema3fb 
MO injection alone resulted in fewer neutrophils being retained 
at the injury site 24 hours after injury (Figure 2, C and D, and Sup-
plemental Figure 2C). Furthermore, an additive effect of sema3fa 
and sema3fb knockdown was observed (Figure 2, C and D). Impor-
tantly, knockdown of sema3fa or sema3fb had no effect on levels of 
neutrophil apoptosis during inflammation resolution in zebrafish 
or on whole-body neutrophil counts (Supplemental Figure 3).
To further confirm our knockdown experiments, we gener-
ated mutant zebrafish on an mpx:GFP background, in which stop 
codons were introduced into the sema3fa and sema3fb genes using 
genome editing with transcription activator–like effector nucleases 
(TALENs) (Supplemental Figure 4). Following tail fin injury, fluores-
cent neutrophil numbers at the inflammatory site were counted at 6 
and 24 hours in progeny from an incross of heterozygotes of either 
sema3fa or sema3fb. Fish were subsequently genotyped and the data 
grouped by genotype. Neutrophil recruitment was independent of 
sema3fa or sema3fb genotype (Figure 2E), confirming our observa-
tions with MO knockdown. There were no significant changes in 
whole-body neutrophil counts in either mutant (Figure 2F). Inflam-
mation resolution was, however, greatly accelerated in homozygous 
mutants of sema3fa or sema3fb (Figure 2G), recapitulating the mor-
phant phenotype. Thus, SEMA3F is necessary for normal neutrophil 
retention at inflammatory sites in zebrafish. To better understand 
the dynamics of neutrophil egress from the injured site, we quanti-
fied the ability of neutrophils to reverse migrate following tail inju-
ry using the neutrophil-specific, photoconvertible Kaede reporter 
transgenic larvae (20). Photoconversion of neutrophils recruited to 
the wound area from green to red enabled the course and location of 
recruited neutrophils to be mapped over time. Injection of transgen-
ic Kaede larvae with sema3fa or sema3fb MOs resulted in increased 
neutrophil reverse migration during inflammation resolution, with 
an additive effect seen when sema3fa and sema3fb MOs were inject-
ed together (Figure 2H).
Neutrophil-specific loss of Sema3f results in more rapid neu-
trophil recruitment to and clearance from the lungs, with retained 
antimicrobial capacity. To further explore the consequence of 
neutrophil expression of SEMA3F for inflammation resolution 
in a mammalian system, we turned to a well-established murine 
model of LPS-induced acute lung injury. In response to LPS chal-
lenge, SEMA3F is released into the airways (Supplemental Figure 
5A), with airspace neutrophils expressing Sema3f transcript and 
SEMA3F protein over an extended time course (Figure 3, A and C, 
and Supplemental Figure 5B). Neutrophils also expressed the obli-
gate coreceptor Nrp2 at both mRNA and protein levels (Figure 3, B 
and D), with 10% of airspace neutrophils demonstrating surface 
expression of NRP2 24 hours after LPS administration, in contrast 
to the alveolar macrophage population (Supplemental Figure 5C). 
NRP1 was not expressed (Figure 3D), replicating the preferential 
expression of NRP2 observed in human neutrophils (Figure 1, B, E, 
and F). Given the expression of SEMA3F by inflammatory neutro-
phils and the proresolution consequence of nonselective SEMA3F 
loss, we questioned whether neutrophil-specific downregulation 
in regulating neutrophil migration and thus the innate immune 
response to tissue injury. Neutrophil clearance from inflamed 
sites is regulated by onset of apoptosis (14), expulsion, and as 
more recently described, reverse migration away from tissues (15–
17). The possibility of active signals retaining neutrophils within 
tissues has been less explored and we hypothesized that in addi-
tion to influencing neutrophil recruitment to tissues, SEMA3F 
might also regulate neutrophil retention at the injury site. Here 
we demonstrate that inflammatory neutrophils express SEMA3F, 
which can directly regulate neutrophil persistence and function 
at the inflamed site. This response is a result of dynamic filamen-
tous-actin (F-actin) disassembly specific to the neutrophil. This 
work highlights a mechanism by which an axon guidance factor 
can both be delivered by inflammatory cells and selectively regu-
late their retention at sites of inflammation.
Results
Inflammatory human neutrophils express SEMA3F and its coreceptor 
NRP2. We have previously established that the Sema3f transcript 
is highly upregulated in recruited PHD3-deficient neutrophils (9). 
This result suggests that neutrophil Sema3f expression is increased 
in the inflammatory niche and may have a role in inflammation. 
We first explored SEMA3F expression in chronic obstructive pul-
monary disease (COPD), a disease characterized by neutrophilic 
inflammation. In tissue sections of surgically resected COPD lung, 
we identified staining for SEMA3F, and the coreceptor neuropilin 2 
(NRP2) (Figure 1A), with NRP2 localized to the recruited CD66b+ 
myeloid cell populations (Figure 1B). Ex vivo, human peripher-
al blood neutrophils increased SEMA3F protein expression in 
response to stimulation with the proinflammatory mediator LPS 
at 4 hours but not at 12 hours (Figure 1, C and D and Supplemen-
tal Figure 1A; see complete unedited blots in the supplemental 
material available online with this article; https://doi.org/10.1172/
JCI130834DS1). Equivalent levels of secreted SEMA3F were 
found between these treatment groups (Supplemental Figure 1B). 
In parallel, we assayed surface expression of SEMA3F receptors 
NRP1 and NRP2. Neutrophils, in contrast to circulating mono-
cytes, preferentially expressed NRP2 rather than NRP1 (Figure 1, 
E and F). Ex vivo, total NRP2 protein expression was not inducible 
above untreated levels at 4 and 12 hours (Figure 1, G and H, and 
Supplemental Figure 1C). Naive and LPS monocytes, in contrast, 
failed to demonstrate expression of either SEMA3F or NRP2 (Sup-
plemental Figure 1, D and E).
Loss of sema3f accelerates inflammation resolution. To under-
stand the consequences of SEMA3F expression for tissue inflam-
mation, we turned to a zebrafish model of inflammation resolu-
tion, in which transgenically labeled neutrophils can be followed 
in transparent larvae during the recruitment and resolution phases 
of inflammation following tissue injury (18). Consistent with the 
idea that Sema3f impacts neutrophil function in this model, anal-
ysis of the single-cell RNAseq resource from zebrafish hemato-
poietic cells reveals that neutrophils express the nrp2 coreceptor 
(http://www.sanger.ac.uk/science/tools/basicz). We therefore 
tested the effects of genetic ablation of sema3f by morpholino- 
modified (MO-modified) antisense oligonucleotide knockdown 
of both zebrafish homologs of human SEMA3F (sema3fa and 
sema3fb) (refs. 18, 19 and Supplemental Figure 2A). While knock-
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6, A–E). Following LPS challenge, Sema3ffl/flMrp8Cre+/– (KO) mice 
exhibited both a greater influx and more rapid rate of clearance 
of these cells (Figure 3E) than Sema3ffl/flMrp8Cre–/– WT littermate 
controls in keeping with more rapid transit of neutrophils through 
of Sema3f was the key determinant for neutrophil egress from the 
lung. We therefore crossed Mrp8 Cre with Sema3ffl/fl lines to gen-
erate a transgenic mouse with Mrp8-driven neutrophil-specific 
knockdown of Sema3f (Sema3ffl/flMrp8Cre+/–) (Supplemental Figure 
Figure 1. Inflammatory human neutrophils express SEMA3F and its coreceptor NRP2. (A and B) Lung sections taken at time of tumor resection from non-
tumor regions of patients with moderate severity COPD were stained for SEMA3F or NRP 2 (A), or a combination of CD66b (green), NRP2 (red), and DAPI (blue) 
(B). Images taken at ×40 magnification. Scale bars: 100 μm in A, 20 μm in B. Human blood neutrophil SEMA3F protein expression following 4 hours culture ex 
vivo was assessed by Western blot (C), and fold change to unstimulated control was determined by densitometry normalized to P38 (D). The percentage of blood 
monocytes (CD66b–, CD14/49D+) and neutrophils (CD66b+) expressing NRP1 and NRP2 was determined in freshly isolated cells (E) and following ex vivo culture 
for 4 hours by flow cytometry in control and stimulated conditions (F). Data are mean ± SEM, with individual data points (n = 3–5) from independent experi-
ments. Human blood neutrophil NRP2 protein expression following 4 hours culture ex vivo was assessed by Western blot (G) and fold change to unstimulated 
control was determined by densitometry normalized to P38 (H). Statistical analysis: 1-way ANOVA and Bonferroni’s post hoc tests (D and H) and 2-way ANOVA 
and Sidak’s post hoc tests (E and F) were performed. *P < 0.05; **P < 0.01; ***P < 0.001.
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Figure 2. Knockdown of semaphorin 3F by MO injection or by TALEN-induced mutation accelerates resolution of neutrophilic inflammation in zebrafish. 
(A–D) sema3fa and/or sema3fb MO (1 nL of 0.5 mM) was injected into 1-cell-stage zebrafish mpx:GFP embryos, with 1 nL of 0.5 mM control MO used as a nega-
tive control. Tail fin transection was performed at 2 dpf, and neutrophils were counted at 6 hpi and 24 hpi. (A) Neutrophil counts at the 6 hpi time point with (B) 
overlaid fluorescence and bright-field photomicrographs (recruitment). (C) Neutrophil counts at the 24 hpi time point with (D) overlaid fluorescence and bright-
field photomicrographs (resolution). Scale bars: 60 μm (B and D). Data are mean ± SEM, with individual data points (n = 30) from 3 independent experiments. 
(E–G) sema3fa- or sema3fb-mutated F1 fish were incrossed and compared with mpx:GFP fish. Tail fin transection was performed at 2 dpf, and (E) neutrophils 
were counted at 6 hpi. Data are mean ± SEM, with individual data points (n = 30) from 4 independent experiments. (F) Whole-body total neutrophil numbers 
were counted at 3 dpf. Data are mean ± SEM, with individual data points (n = 60) from 4 independent experiments. (G) Tail fin transection was performed at 2 
dpf and neutrophils were counted at 24 hpi. Data are mean ± SEM, with individual data points (n = 5–60) from 4 independent experiments. (H) sema3fa and or 
sema3fb MOs (1 nL of 0.5 mM) were injected into 1-cell-stage zebrafish mpx:kaede embryos, and tail fin transection was performed at 2 dpf. Neutrophils at 6 hpi 
were recruited to the wound and photoconverted, and red fluorescence neutrophils were tracked for 3.5 hours. Data are from 3 independent experiments (n = 9). 
Statistical analysis was by 1-way ANOVA and Bonferroni’s post hoc test. ***P < 0.001.
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matory site. No effects on levels of neutrophil apoptosis during 
inflammation resolution or whole-body neutrophil numbers were 
observed (Supplemental Figure 9). In keeping with the importance 
of SEMA3F signaling in retaining neutrophils at inflammatory 
sites, injection of either sema3fa or sema3fb RNA led to a reduced 
number of photoconverted neutrophils moving away from the site 
of tail transection (Figure 5E). This was paralleled with a reduction 
in speed of migration (Figure 5F) but equivalent path straightness 
(meandering index) (Figure 5G) when tracking neutrophil move-
ment over 1 hour during the recruitment phase of inflammation. 
Using a reporter zebrafish line that indicates intracellular PI3ki-
nase activity by recruitment of a GFP-AKT pleckstrin homology 
(PH) domain fusion protein to phosphoinositide products on the 
neutrophil cell membrane, we observed that SEMA3F overexpres-
sion did not affect the ability of the neutrophils to generate a lead-
ing edge, as judged by activation of PI3K at the plasma membrane 
(Figure 5H and ref. 3).
Exogenous SEMA3F retains recruited neutrophils at the injury 
site in a murine model of acute lung injury. To investigate the effects 
of exogenous SEMA3F on inflammation resolution in the murine 
model of acute lung injury, 24 hours after LPS challenge, SEMA3F 
(1 μM) was instilled into the trachea of mice and total cell and neu-
trophil differential counts were performed at 48 and 72 hours (Fig-
ure 6A). More neutrophils were recovered from the 48-hour BAL 
samples of mice receiving exogenous SEMA3F than from PBS con-
trol (Figure 6A). Again, this occurred despite equivalent apoptosis 
counts between SEMA3F-treated and SEMA3F-naive mice. Quan-
tifying the localization of neutrophils in fixed lung slices as before, 
this increase in BAL neutrophil counts was paralleled by a decrease 
in the vascular space and an increase in neutrophils within the alve-
olar compartment, the compartment in which neutrophil exposure 
to exogenous SEMA3F occurred (Figure 6B). Given the observed 
difference in speed of neutrophil movement in the tail of zebra-
fish larvae, we tested whether exogenous SEMA3F could also act 
to alter the speed of neutrophil movement in the lung. Imaging live 
lung slices from Ly6G-driven fluorescent reporter mice (21, 22) in 
which murine neutrophils express the reporter tdTomato, we quan-
tified mean neutrophil speed (Figure 6C), maximum speed (Figure 
6D), and track straightness (track straightness was determined by 
dividing the distance between first and last position by the length 
of the tracks) (Figure 6E). Live lung slice cultures harvested from 
naive mice were subject to in vitro stimulation with SEMA3F or 
vehicle control at 30 minutes and neutrophil behavior was record-
ed for 60 minutes. Baseline neutrophil behavior during the first 30 
minutes was similar between paired slices (Supplemental Figure 
10). SEMA3F significantly reduced both mean and maximum neu-
trophil speed (Figure 6, C and D) while neutrophil track straight-
ness remained unchanged (Figure 6E). Thus, neutrophils move 
more slowly when exposed to SEMA3F and as a consequence are 
retained at sites of inflammation.
Human neutrophil treatment with exogenous SEMA3F blocks 
chemotaxis while preserving phagocytosis and respiratory burst activ-
ity. To more broadly assess the ability of SEMA3F to regulate key 
human neutrophil functions, human peripheral blood neutrophils 
were cultured ex vivo in the presence of recombinant SEMA3F. 
Using a Transwell assay, we demonstrated that although SEMA3F 
is not a chemoattractant itself, incubation with SEMA3F inhibits 
the lung compartment and loss from the airspace when they lack 
Sema3f. The resolution of neutrophilic inflammation occurred 9.1 
hours earlier in the KO mice compared with WT mice, where res-
olution is defined as the time taken to reach a 50% reduction in 
the neutrophil number from peak counts. This was matched with 
a significant reduction in bronchoalveolar lavage (BAL) IgM lev-
els between 24 and 48 hours in the Sema3f-deficient mice (Figure 
3F). Importantly, at all time points shown, there was no observed 
difference in the percentage of neutrophils undergoing apoptosis 
between the genotypes (Figure 3G).
To define how neutrophil-specific loss of Sema3f regulated air-
way neutrophil counts in the face of preserved apoptosis rates, we 
examined peripheral blood (Figure 4A and Supplemental Figure 
6F) and whole lung neutrophil counts following lung digest (Fig-
ure 4B and Supplemental Figure 6G). We observed equivalent 
circulating and tissue neutrophil counts among genotypes up to 
6 hours after LPS challenge and therefore tested whether differ-
ences in airway neutrophil counts observed reflected differential 
neutrophil transit among intravascular, perivascular, and alveolar 
compartments. Using 3D reconstruction of fixed lung slices we 
compared neutrophil localization in lungs harvested from WT and 
KO mice (Figure 4C). In keeping with more rapid transit through 
the lung tissue, a greater proportion of neutrophils were identi-
fied in the alveolar compartment of mice deficient in neutrophil 
Sema3f at 6 hours (Figure 4D and Supplemental Figure 6H), with 
equivalent numbers in the blood (Figure 4A) and lung tissue (Fig-
ure 4B and Supplemental Figure 6I), and clearance by 48 hours 
(Supplemental Figure 6H).
To delineate whether the inflammatory response of Sema3ffl/fl 
Mrp8Cre+/– was sufficient to control a fulminant infection, mice 
were challenged with intratracheal high-dose serotype 2 Strepto-
coccus pneumoniae. Mice lacking Sema3f in the neutrophil com-
partment were able to mount an effective antimicrobial response 
with equivalent temperature and sickness scores (Supplemental 
Figure 7, A and B) and lung CFU counts (Figure 4E). In keeping 
with the LPS response, neutrophils transited more rapidly from 
the circulation (Supplemental Figure 7C) through the lung into the 
airspace compartment in the absence of Sema3f (Figure 4F).
Upregulated sema3f expression causes aberrant neutrophil reten-
tion in tissue. Having shown that genetic ablation of Sema3f in vivo 
leads to premature neutrophil release from inflammatory sites, 
we sought evidence that SEMA3F is sufficient to restrain neutro-
phils’ migratory behavior during inflammation. Zebrafish sema3fa 
and sema3fb were cloned from cDNA and capped mRNA for each 
was transcribed in vitro then microinjected into fertilized eggs. 
Overexpression of sema3fa or sema3fb was confirmed by in situ 
hybridization (Supplemental Figure 8). Overexpression of either 
sema3fa or sema3fb resulted in a significant reduction in neutro-
phil recruitment to the injury site compared with larvae in which 
mCherry control mRNA was injected or to uninjected controls 
(Figure 5, A and B). When followed over time, neutrophils in larvae 
injected with mRNA for either sema3fa or sema3fb showed delayed 
clearance of neutrophils from the injury site when compared with 
uninjected and mCherry injected controls (Figure 5, C and D). The 
magnitude of the response was equivalent for both sema3fa and 
sema3fb with no additive effect observed, suggesting that either 
sema3fa or sema3fb could act to retain neutrophils at the inflam-
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ex vivo human neutrophils migrating toward the chemoattractant 
formyl-methionyl-leucyl phenylalanine (fMLF) (Figure 7A). To 
further investigate the effect of SEMA3F on neutrophil migra-
tion, we used a microfluidic chip assay providing bidirectional 
real-time data with a stable LTB4 chemoattractant gradient (23). 
SEMA3F preincubation resulted in a significant dose-dependent 
reduction in recruitment (Figure 7B). Moreover, after reaching 
the inflection point (where maximal recruitment is achieved) 
the highest dose of SEMA3F, 1000 nM, was able to retain neu-
trophils within the chamber. In this setting, SEMA3F treatment 
of human peripheral blood neutrophils ex vivo did not alter neu-
trophil surface expression of key adhesion receptors CD11b or L 
selectin (Supplemental Figure 11, A and B). Phagocytosis is also 
an important cytoskeletal neutrophil function that, like migra-
tion, is regulated by cell shape and actin dynamics. SEMA3F 
treatment did not inhibit phagocytosis of either bacteria (E. coli) 
Figure 3. Neutrophil-specific loss of Sema3f results in more rapid neutrophil recruitment to and clearance from the lungs in a murine acute lung injury mod-
el. (A and B) Fold change in Sema3f and Nrp2 gene expression following acute lung injury with LPS. Mice were sacrificed at 6, 24, and 48 hours after instillation. 
BAL neutrophils were collected and cDNA was extracted. TaqMan analysis of cDNA was performed with data normalized to murine Actb gene expression. Data 
are mean ± SEM of fold change compared with peripheral blood neutrophils (T0 PB) from 2 individual experiments (n = 4–6). An acute lung injury was induced 
by intratracheal LPS instillation, mice were sacrificed at 24 hours, and lung sections were stained for expression of the Ly6G neutrophil marker and SEMA3F (C), 
NRP1, and NRP2 (D). Scale bars: 50 μm. (E and F) Sema3ffl/flMrp8Cre–/– (WT) and Sema3ffl/flMrp8Cre+/– (KO) mice were challenged with LPS, sacrificed at 2, 6, 
24, and 48 hours, and BAL fluid was obtained. Cell counts were performed by hemocytometer and the differential cell count was established by cytospins. 
Time to 50% reduction in peak neutrophil number was calculated individually for each genotype (T50) (E). BAL fluid IgM content was measured by ELISA. 
Data are shown as log-transformed fold change from WT (F). Apoptosis was assessed by morphology, with data as mean ± SEM (G) from 3 individual 
experiments (n = 6–12). Statistical analysis was by 1-way ANOVA and Bonferroni’s post hoc test (A and B) and 2-way ANOVA with Sidak’s post hoc test (E–G).  
*P < 0.05; **P < 0.01; ***P < 0.001.
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or yeast (Zymosan) by neutrophils (Figure 7, C and D). Surpris-
ingly, SEMA3F augments the capacity of neutrophils to mount a 
respiratory burst response to fMLF (Figure 7E) while preserving 
neutrophil degranulation determined by measure of extracellular 
elastase activity in neutrophil supernatants (Figure 7F).
SEMA3F promotes neutrophil rounding and F-actin disassembly. 
To investigate the mechanism by which SEMA3F slows neutro-
phil migration in vivo, we returned to the zebrafish model system. 
We focused on the potential of SEMA3F to mediate its effect by 
alterations in F-actin polymerization in light of the observations 
that during axonal growth cone collapse, the class 3 semaphorin 
SEMA3A induces F-actin reorganization, and the reports that 
F-actin polarization is important for neutrophil motility (24–28). 
Using a transgenic zebrafish line in which F-actin fluoresces red 
(4, 29) we observed that sema3fa and sema3fb RNA overexpres-
sion resulted in a reduction in overall F-actin levels (Figure 8, A 
and B) and an increase in neutrophil rounding (Figure 8, B and 
C). High content wide-field imaging revealed an increase in neu-
trophil rounding in human peripheral blood neutrophils when 
treated in vitro with SEMA3F and was recapitulated using Airy-
scan confocal imaging shown in the representative images (Fig-
ure 8, D and E). This neutrophil rounding was associated with a 
reduction in end steady state F-actin levels following stimulation 
of neutrophils with fMLF (Figure 8, F and G). To address whether 
changes in F-actin levels were consequent, in part, upon chang-
es in actin turnover, we quantified F-actin localization following 
neutrophil treatment with SEMA3F. In keeping with defective 
turnover, SEMA3F induced aberrant distribution of F-actin fila-
ments (Figure 8H and Supplemental Figure 11C). To further test 
the hypothesis that in neutrophils SEMA3F promotes F-actin dis-
assembly, neutrophil rounding, and retention within the airways, 
we studied fixed lung slices harvested from WT mice challenged 
Figure 4. Neutrophil-driven deletion of Sema3f favors a selective allocation of neutrophils in the alveolar space while retaining antimicrobial capacity. (A 
and B) Sema3ffl/flMrp8Cre–/– (WT) and Sema3ffl/flMrp8Cre+/– (KO) mice were challenged with nebulized LPS and sacrificed at 0, 2, and 6 hours following LPS 
challenge. Blood and lung tissues were harvested with lung digest for Ly6G staining (neutrophil number). In a parallel series of experiments, lungs were 
instilled with agarose gel at 6 hours, then fixed and stained with the endothelial marker CD31 (green) and the neutrophil marker S100A9 (red). Lungs were 
imaged by confocal microscopy (Zeiss LSM 880 with Airyscan) with 3D reconstruction and neutrophil position relative to the blood vessels assigned, using 
Imaris software version 9.1 (neutrophil, white arrows) (C). Percentage of total neutrophils per 106 μm3 lung tissue is shown, with a minimum of 190 neutro-
phils quantified per mouse (D). Data are mean ± SEM from 3 individual experiments (n = 3–5). (E and F) WT and KO mice were challenged with intratracheal 
instillation of S. pneumoniae, and lung bacterial counts (E) and BAL and lung neutrophil counts (F) were undertaken 14 hours after challenge. Data are mean 
± SEM from 2 individual experiments (n = 6–10). Statistical analysis was by 2-way ANOVA with Sidak’s post hoc test (A, B, and D) and Mann-Whitney (E) and 
1-tailed unpaired t test (F). *P < 0.05.
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the injury site represents a mechanism through which the longevi-
ty of the inflammatory response may be regulated.
Using zebrafish models, we showed that SEMA3F regulates 
neutrophil migration speed, but not directionality, with conse-
quences for both neutrophil recruitment and tissue retention. This 
was recapitulated in a murine model of lung injury, where SEMA3F 
was seen to control neutrophil recruitment and retention at the 
injury site. The relevance of this response to human neutrophil 
behavior was supported by our observation that while exogenous 
SEMA3F does not act as a chemoattractant, it profoundly inhibits 
neutrophil chemotaxis to fMLF and LTB4 and is an active reten-
tion signal. The ability of axon guidance molecules to regulate 
leukocyte migration has been previously described both in lym-
phocytes and HL-60 cells, with the neuronal repellent Slit inhib-
iting chemotactic responses in vitro to stromal cell–derived factor 
1 (SDF-1a) (30), and recently, the regulation of trans-endothelial 
neutrophil migration by HIF-dependent endothelial expression of 
SEMA7A has also been investigated (31). These observations are 
further supported by the finding that T lymphocyte transmigra-
tion can be modified by gene silencing of the collapsin response 
mediator protein 2, a previously characterized effector of sema-
phorin-induced growth-cone collapse (32). SEMA3E, another 
class 3 semaphorin, signals independently of NRP coreceptor 
expression, unlike SEMA3F (33). More recently, Movassagh et 
al. identified that SEMA3E was a chemorepellent and modulator 
of neutrophil migration in the context of chronic allergen-driven 
lung inflammation, in a whole animal Sema3e–/– murine model 
(34). Our work both extends the role of class 3 semaphorins in 
regulating neutrophil movement to include SEMA3F and raises 
the concept of active neutrophil retention within the inflamed 
site. With induction of SEMA3F observed in neutrophils recruit-
ed in response to tissue injury, sterile inflammation, and patho-
gen challenge, this raises the interesting possibility that a number 
of divergent signals, including for example damage associated 
molecular patterns (DAMPs) and pathogen associated molecular 
patterns (PAMPs), may act in concert to actively retain neutrophils 
within the inflammatory niche. Within the lung tissue, retention 
of neutrophils has important consequences for inflammation res-
olution, as evidenced by the increase in neutrophil clearance in 
mice lacking SEMA3F within the neutrophil compartment. In the 
lung, expectoration of neutrophils from the airspace represents a 
major mechanism of clearance, in addition to neutrophil apopto-
sis both in the airspaces and lung interstitium. While perivascular 
reverse migration of neutrophils is observed, there are currently 
no data to suggest that neutrophils can return to either the vascu-
lature or lymphatics once they have entered the airways. Thus, the 
transition times of neutrophils between the different lung com-
partments will dominate rates of inflammation resolution in the 
setting of differential SEMA3F expression, where effects on neu-
trophil apoptosis are not observed.
Within axons, actin rearrangement is observed following acti-
vation of semaphorin signalling pathways. In our experiments, 
we also observed that SEMA3F promotes neutrophil rounding in 
association with F-actin disassembly and persistence within the 
airspaces. Taken together, these data suggest a mechanism by 
which neutrophil expression of SEMA3F selectively regulates neu-
trophil retention within the inflammatory site as a consequence of 
with nebulized LPS and treated with SEMA3F or control PBS ex 
vivo. SEMA3F treatment increased both the percentage of neutro-
phils that are highly round and the mean sphericity of neutrophil 
populations within the lung tissue (Figure 8, I and J). To assess 
alterations in F-actin polymerization, we quantified the ratio of 
F/G actin within each airway neutrophil. In keeping with loss of 
F-actin content, mice exposed to SEMA3F had significantly lower 
F/G actin ratios per neutrophil than SEMA3F-naive controls (Fig-
ure 8K). There is a dynamic balance between neutrophil migration 
between and retention within the different compartments of the 
lung, and consequence for effective immunity and inflammation 
resolution (Figure 9).
Discussion
To date, effective therapeutic strategies that target persistent neu-
trophilic inflammation remain an important unmet clinical need. 
In this work, we identify a mechanism by which inflammatory 
cells can deliver a neutrophil-specific retention signal to the injury 
site in the form of a secreted axon guidance molecule, SEMA3F. 
Initial phenotyping revealed, both acutely in a murine LPS model 
of lung injury and chronically in lung sections from patients with 
COPD, that recruited myeloid cells express the class 3 semaphorin 
SEMA3F and its high-affinity coreceptor NRP2. With evidence 
that CD66b+ cells express NRP2 in the interstitium and alveolar 
space, and that LPS upregulates SEMA3F protein expression, these 
data together speak of a dynamic SEMA3F/NRP2 axis within the 
inflammatory neutrophil compartment. While neutrophil produc-
tion and release of preformed and newly synthesized factors that 
modify outcomes of key neutrophil responses (including patho-
gen clearance, recruitment, and survival) are well established, the 
expression of molecules that function to retain neutrophils within 
Figure 5. Overexpression of sema3f in a zebrafish model of inflamma-
tion delays neutrophil recruitment and resolution of the inflammatory 
response. (A–D) sema3fa or sema3fb RNA (50 ng/μL) was injected into 1-cell-
stage zebrafish mpx:GFP embryos, with 50 ng/μL mCherry RNA used as a 
negative control. Tail fin transection was performed at 2 dpf, and neutrophils 
counted at 6 and 24 hpi. (A) Neutrophil counts at the 6 hpi time point with 
(B) overlaid fluorescence and bright-field photomicrographs (recruitment). (C) 
Neutrophil counts at the 24 hpi time point with (D) overlaid fluorescence and 
bright-field photomicrographs (resolution). Scale bars: 60 μm (B and D). Data 
are mean ± SEM with individual data points from 3 independent experi-
ments (n = 30). (E) sema3fa and/or sema3fb RNA (50 ng/μL) were injected 
into 1-cell-stage zebrafish mpx:kaede embryos, and tail fin transection 
was performed at 2 dpf. Neutrophils recruited to the wound at 6 hpi were 
photoconverted, and red fluorescent neutrophils were tracked for 3.5 hours. 
Data are mean ± SEM from 3 independent experiments (n = 9). (F and G) 
sema3fa or sema3fb RNA (50 ng/μL) was injected into 1-cell-stage zebrafish 
mpx:GFP embryos, with 50 ng/μL mCherry RNA used for control. Tail fin 
transection was performed at 2 dpf. Neutrophil movement was tracked over 
1 hour by time-lapse microscopy during the recruitment phase of inflamma-
tion (1–2 hpi) and speed of neutrophil migration (F) and meandering index 
(displacement/path length) (G) were determined. Data are mean ± SEM from 
3 independent experiments (each point represents a single neutrophil) (n = 
15). (H) sema3fa or sema3fb RNA (50 ng/μL) was injected into 1-cell-stage 
Tg(lyz:PHAkt-EGFP) embryos with noninjected controls, tail fin transection 
was performed at 2 dpf, and polarity indices were calculated for neutrophils 
recruited to the tail region. Data are mean ± SEM from a single experiment  
(n = 8). Statistical analysis was by 1-way ANOVA and Bonferroni’s post hoc 
test. ***P < 0.001.
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in the face of preserved leading edge PI3kinase activity, preserved 
directional migration, and critically preserved neutrophil effector 
functions. This is in keeping with SEMA3F acting downstream of 
the PH domain proteins, with F-actin disassembly and aberrant 
F-actin distribution, and turnover selectively affecting neutrophil 
retention in the face of preserved antimicrobial effector function. 
promoting F-actin disassembly and suppressed neutrophil migra-
tory speeds. Future work to explore the mechanisms by which neu-
trophil SEMA3F expression regulates neutrophil retention within 
the tissue and whether this is a cell autonomous mechanism or 
dependent on the presence of other immune cell populations (e.g., 
alveolar macrophages) will be of interest. Importantly, this occurs 
Figure 6. Exogenous SEMA3F retains recruited 
neutrophils at the injury site in a murine model 
of acute lung injury. (A and B) Intratracheal (IT) 
recombinant SEMA3F (1 μM) was administered 
to C57BL/6 mice 24 hours after nebulized LPS 
challenge or PBS. Mice were then sacrificed at 
48 and 72 hours and BAL was performed with 
differential apoptosis cell/neutrophil counts 
(A), or lungs were retained for fixed lung slice 
imaging (B). Lungs harvested for lung imaging 
were instilled with agarose gel, and fixed and 
stained with the endothelial marker CD31 (green) 
and the neutrophil marker S100A9 (red). Lungs 
were imaged by confocal microscopy (Zeiss LSM 
880 with Airyscan) with 3D reconstruction and 
neutrophil position relative to the blood vessels 
was assigned using Imaris software version 
9.1, with at least 80 neutrophils quantified per 
mouse. Data are mean ± SEM with individual 
data points from 4 independent experiments (n = 
12). (C–E) Naive Catchup (IVM-RED;Lifeact-GFP) 
mice were sacrificed and lungs were instilled 
with agarose gel, precision sliced, and imaged by 
confocal microscopy for 90 minutes with addition 
of SEMA3F or PBS vehicle control at 30 minutes. 
Following treatment, neutrophil mean speed 
(C), maximum speed (D), and track straightness 
(directionality) (E) were measured and analyzed 
for 60 minutes using Imaris software version 
9.1. Data are from 3 independent experiments 
(n = 3). Statistical analysis was by 2-way ANOVA 
and Sidak’s post hoc test (A and B) or paired t test 
(C–E). *P < 0.05; **P < 0.01; ****P < 0.0001.
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that was sufficient to control bacterial numbers where animals 
were exposed to a bacteremic model of streptococcal pneumonia. 
With a dissociation between the consequences of Sema3f loss on 
neutrophil migratory speed versus respiratory burst generation 
and bacterial clearance, an important future direction of this work 
will be to dissect the downstream mechanisms by which neutro-
phils retain key effector functions in the face of aberrant F-actin 
turnover and distribution.
Thus we propose that SEMA3F acts as a break in neutrophil move-
ment among the different vascular, interstitium, and airspace 
compartments within the lung.
Finally, when considering the therapeutic utility of targeting 
SEMA3F to promote inflammation resolution, the consequence of 
Sema3f loss within the neutrophil compartment on effective anti-
microbial responses was explored in vivo. Importantly, neutrophils 
deficient in Sema3f were able to mount an antimicrobial response 
Figure 7. Neutrophil treatment with exogenous SEMA3F blocks chemotactic responses while preserving phagocytic capacity and respiratory burst functions. 
(A–F) Isolated peripheral blood neutrophils from healthy volunteers were incubated with recombinant SEMA3F (0–100 nM), and functional assays were 
performed. (A and B) Chemotactic behavior of neutrophils to fMLF (0–100 nM) and LTB4 were measured by Boyden chamber, CC chemokinesis control 
(A), and microfluidic chip assay (B). (C) Neutrophils were incubated with Alex 488 E. coli and phagocytic uptake was determined by flow cytometry, with 
adhesion excluded by 4°C control. (D) Phagocytic indices were calculated by cytospin following neutrophil culture with opsonized Zymosan particles for 
30 minutes. (E) ROS generation was determined following a 1 hour preincubation with SEMA3F and treatment with fMLF for 30 minutes. (F) Neutrophil 
release of elastase was measured by fluorimetric assay following pretreatment with 1 hour of SEMA3F, 30 minutes of GM-CSF (10 ng/mL), and 10 minutes 
of fMLF (100 nM). All data are mean ± SEM with individual data points from independent experiments (n = 3–6). Statistical analysis was by 1-way ANOVA and 
Sidak’s post hoc test (A, B, E, and F) or paired t test (C–E). *P < 0.05; **P < 0.01; ****P < 0.0001.
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erichia coli (10 ng/mL, Enzo Life Sciences), IL-1b (100 ng/mL, AMS 
Biotechnology), TNFa (100 ng/mL, AMS Biotechnology), or LTB4 
(100 nM, Cayman Chemical) for 4 to 12 hours.
Protein expression. Lysates were prepared using sonication in a 
BioruptorPLUS iced water bath (Diagenode Europe SA) and added to 
lysis buffer. Following SDS-PAGE protein separation (7.5% gels were 
appropriate for all proteins studied), transfer of proteins to a PVDF 
membrane was performed using a Bio-Rad Mini Trans-Blot cell at 100 
V for 90 minutes. Intercept (PBS) blocking buffer (Li-Cor) was used to 
block blots and dilute primary and secondary antibodies. Primary anti-
bodies were directed against SEMA3F (1:100; LS-C135015, Life Span 
Biosciences) and NRP2 (1:100; HPA054974, Atlas Antibodies), and 
P38 (1:2000; ab197348, Abcam) was used as a loading control. Blots 
used for the detection of SEMA3F were incubated with horseradish 
peroxidase–conjugated (HRP-conjugated) anti-rabbit (1:2000; P0448, 
Dako), and blots used for the detection of NRP2 were incubated with 
IRDye800CW-conjugated anti-rabbit (1:2000; 926-32213, Li-Cor). 
Signals were detected using an Odyssey FC Imaging System (Li-Cor) 
and protein expression was quantified by scanning densitometry and 
normalized to the expression of P38. Enzyme-linked immunosorbent 
assay (ELISA) was performed according to the manufacturer’s proto-
col to quantify SEMA3F levels (Cloud-Clone Corporation) in super-
natants of human blood neutrophils following 4 hours culture ex vivo 
with inflammatory stimuli, IgM levels (Abcam) in BAL fluid from mice 
either after 24 or 48 hours after nebulization with LPS (Sigma-Aldrich, 
1 mg), or after 14 hours post-intratracheal instillation of 107 S. pneumo-
niae D39 type 2 strain. Flow cytometry was performed to analyze sur-
face expression of L selectin and CD11b by using anti–L selectin [PE] 
(BD Pharmingen) and anti-CD11b [PE] (BD Pharmingen), respectively.
Isolation and RNA quantification of human and murine neutrophils. 
Human peripheral blood neutrophils were isolated as described above, 
with murine peripheral blood neutrophils isolated from WT C57BL6 
mice by negative magnetic selection (Easysep; STEMCELL Technol-
ogies) and inflammatory neutrophils were recovered from BAL fluid 
following challenge with 1 mg nebulized LPS. RNA was extracted using 
the mirVana total RNA isolation protocol (Ambion). Samples were 
treated with DNAse (Ambion) and random hexamer cDNA was synthe-
sized by reverse transcription. TaqMan commercially available primer 
probe sets were obtained from Applied Biosystems for the target assay 
(Sema3f) and the endogenous control assay (actb) (Applied Biosystems).
Quantification of murine neutrophil numbers and NRP2 surface 
expression during LPS-mediated acute lung injury and intratracheal S. 
pneumoniae infection. Murine venipuncture was performed direct-
ly following humane killing and full blood counts were conducted 
using the Coulter counter method by the clinical pathology service at 
the Royal Dick Veterinary School, Edinburgh, Scotland. For S. pneu-
moniae–infected mice, blood was harvested from abdominal aorta 
after humane killing and nucleated blood cells were counted using an 
automated cell counter (Biorad) after red blood cell lysis (BioLegend). 
Total viable neutrophil counts were obtained after blocking unspecif-
ic staining with Fc block (BioLegend) and using live/dead aqua dye 
(Applied Biosystems) in combination with the following antibodies 
(BioLegend): anti-CD45 [AF700] (clone 30-F11), anti-CD11b [BV450] 
(clone M1/70), and anti-Ly6G [PE] (1A8). For total lung counts or after 
infection, lung digest was performed with Collagenase V (Sigma- 
Aldrich), Collagenase D (Roche), DNAse I (Roche), and Dispase (Gib-
co). Following red cell lysis (Sigma-Aldrich), viable cell counts were 
In summary, our work aims to elucidate how neutrophils 
respond to signals within an inflamed microenvironment that 
induce them to persist. We identify SEMA3F as a neutrophil reten-
tion signal with effects conserved across a number of different spe-
cies (fish, mouse, and human). These observations have import-
ant implications for inflammation resolution and tissue injury and 
are of interest given both the current lack of effective therapeutic 
strategies for treating neutrophil inflammation and the potential 
to selectively target the neutrophil retention response.
Methods
Immunohistochemistry. Murine paraffin-embedded blocks were pre-
pared from lungs fixed via the trachea with 10% buffered forma-
lin at 20 cm H2O. Serial sections were stained with anti-Ly6G clone 
1A8 (ab25377, Abcam) and the following polyclonal antibodies: anti-
SEMA3F (SAB2700501, Sigma-Aldrich), NRP1 (AF3870, R&D Sys-
tems), NRP2 (H300, Santa Cruz Biotechnology), or an isotype control 
following deparaffinization. Lung sections from patients with COPD 
undergoing resection for suspected lung tumor were stained with anti-
SEMA3F, NRP2, or isotype control, and visualized with DAB or stained 
with anti-CD66b (555723, BD Biosciences), anti-NRP2 (HPA054974, 
Atlas Antibodies), and DAPI (422801, Sigma-Aldrich) with TSA plus 
system amplification (NEL744B001KT, Perkin Elmer) and autofluo-
rescence quenching with TrueView (Vector, SP-8400).
Isolation and culture of human blood neutrophils. Human peripheral 
blood neutrophils were isolated from whole blood using dextran sed-
imentation and discontinuous plasma-Percoll gradients. Cells were 
cultured 5 × 106 cells/mL in RPMI 1640 supplemented with 10% FCS 
and 1% penicillin/streptomycin at 37°C in a humidified incubator with 
5% supplemental CO2 in the presence or absence of LPS from Esch-
Figure 8. SEMA3F promotes neutrophil rounding and F-actin disassem-
bly. (A–C) sema3fa or sema3fb RNA (50 ng/μL) was injected into 1-cell-
stage Tg(mpx:LifeActRuby) embryos, tail fin transection was performed 
at 2 dpf, and neutrophil fluorescence intensities were calculated (A). 
Representative images (B). White arrows indicate the direction to the 
wound edge. Roundness scores were calculated for neutrophils recruited 
to the injury (C). Data are mean ± SEM from an single experiment (n = 
9). (D–G) Human blood neutrophils were pretreated with PBS or 100 nM 
SEMA3F before stimulating with PBS or 100 nM fMLF. Following DAPI/cell 
mask/phalloidin staining, neutrophil rounding was quantified by high-con-
tent widefield microscopy (1 = perfect sphere), with more than 1000 cells 
measured per condition (D). Pixel intensity for phalloidin was obtained 
using confocal microscopy (×100 objective), scale bars: 5 μm (E). F-actin cell 
content was quantified with more than 1000 cells measured per condition 
(F and G) and distribution was used to calculate a polarity index (H). Data 
are mean ± SEM from 4 independent experiments (n = 4–22). (I–K) Intra-
tracheal SEMA3F (1 μM) was administered to C57BL/6 mice 24 hours after 
nebulized LPS or PBS, and lung tissue (I and J) or BAL fluid (K) was collect-
ed at 48 hours. Lungs were instilled with agarose gel, fixed and stained 
with the endothelial CD31 and the neutrophil marker S100A9, and imaged 
by confocal microscopy. The percentage of neutrophils of each sphericity (I) 
and the mean sphericity of neutrophils (J) was defined. F/G actin ratios per 
cell were calculated from fluorescence intensities following staining with 
phalloidin (F-actin) and DNAse 1 (G-actin), with a latrunculin B (LTNB) neg-
ative control (K). Data are mean ± SEM from 2 independent experiments (n 
= 9) (I–K). Statistical analysis was by 1-way ANOVA and Bonferroni’s post 
hoc test (A–D and H), with Sidak-Holm multiple comparison posttest (K) 
and paired t test (G) performed for time points 15 to 30 minutes during the 
steady state of F-actin turnover, and unpaired t test (I–J). *P < 0.05, **P < 
0.01, ***P < 0.001, ****P < 0.0001.
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i277, Tg(mpx:LifeActRuby)sh429, and macrophage-specific fluorescent 
zebrafish line Tg(fms:GAL4.VP16)i186;Tg(UAS:nfsB.mCherry)c624. 
Transcription activator–like effector nuclease (TALEN) technology was 
used to induce frameshift mutations in sema3fa and sema3fb genes. Fer-
tilized eggs were injected with RNAs coding for heterodimers of a left 
and right subunit containing a C-terminal Fok1 nuclease domain and 
an N-terminal site-specific DNA binding domain, specifically target-
ing sema3fa or sema3fb using the tool on http://talent.cac.cornell.edu/
node/add/talen-old, with TALE repeats designed to flank the Mwol 
(sema3a) and BsII (sema3b) restriction endonuclease restriction site of 
exon 8 as previously described (15, 16). Germline mutation was veri-
fied by genomic PCR from larval pools of the F1 or F2 zebrafish using 
5′-GGCGACGAGGTGGTCGTTGG-3′ and 5′-CATCGCGCAATGCA-
CTGAC-3′ primers and appropriate restriction enzyme digest.
sema3f knockdown and overexpression in the zebrafish models. DNA 
was subcloned from plasmid constructs gifted by C. Moens (Univer-
sity of Washington, Seattle, Washington, USA) containing full-length 
zebrafish sema3fa and sema3fb in pCR4 vectors, RNA transcribed by 
mMessageMachine (Ambion) and microinjected into one-cell-stage 
embryos. All MOs were from Genetools. One-cell-stage embryos were 
microinjected with pre-mRNA translation blocking MO to sema3fa 
(17) or splice blocking MO targeting the exon3/5 boundary of sema3fb, 
5′TATGAAGCGATACTCACGTTTGTGT3′. Efficacy of sema3fb 
knockdown was confirmed by RT-PCR (Supplemental Figure 2). The 
control MO was CCTCTTACCTCAGTTACAATTTATA.
performed using live/dead aqua dye (Applied Biosystems). Immune 
cell populations were identified after Fc block (BioLegend) using the 
following markers (all from BioLegend): anti-Siglec F [PE-CF594] 
(clone S17007L ), anti-CD11b [BV450] (clone M1/70), anti-Ly6C 
[FITC] (clone HK1.4), anti-Ly6G [PE] (clone 1A8), anti-MHC II 
[PerCP-Cy5.5] (clone C068C2), anti-CD11c [PE-Cy7] (clone N418), 
anti-CD64 [APC] (clone X54-5/7.1), and anti-CD45 [AF700] (clone 
30-F11). BAL fluid was harvested from mice after LPS or after infec-
tion and total nucleated cell counts were obtained either with hemocy-
tometer or NucleoCounter (Chemometec). Total viable counts for the 
different immune populations were obtained by using either cytospins 
or the same markers used for lung tissue. Flow cytometry was per-
formed to analyze NRP2 surface expression by using anti-NRP2 [APC] 
(clone 257103; R&D Systems).
Bacterial viable counts. Fourteen hours after infection with 107 
serotype 2, S. pneumoniae left lung was homogenized in sterile condi-
tions by using a tissue homogenizer (Bullet Blender) and lysing tubes 
(Precellys). Ten-fold serial dilutions were plated into blood agar plates, 
grown overnight at 37°C and 5% CO2, and CFU counts determined.
Zebrafish lines. Adult zebrafish were maintained on a 14-hour-
light/10-hour-dark cycle at 28°C in United Kingdom Home Office–
approved facilities in the Bateson Centre aquaria at the University 
of Sheffield. The following neutrophil-specific fluorescent zebrafish 
lines were used: Tg(mpx:GFP)i114 (called mpx:GFP in the text for clar-
ity), Tg(mpx:GAL4)sh267;Tg(UAS:kaede)s1999t, Tg(lyz:PHAkt-EGFP)
Figure 9. A summary of the migratory movement of neutrophils in Sema3f knockdown and overexpression models of acute lung injury. Neutrophil-specific 
KO of Sema3f increased neutrophil transit through the airways and led to more rapid clearance of neutrophils from the alveolar space, resulting in faster resolu-
tion. In contrast, overexpression of Sema3f in the airspaces caused neutrophil retention and delayed inflammation resolution.
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Cy3 Affini Pure Donkey anti-rat IgG (712-165-150, Jackson Immuno-
Research Laboratories), goat anti-hamster IgG (H+L) Cross-Adsorbed 
Secondary Antibody, Alexa Fluor 488 (A-21110, Thermo Fisher Sci-
entific) and DAPI. Lung slices were fixed and mounted using Mowiol 
with 2.5% DABCO (1,4-diazabicyclo-[2,2,2]-octane; Sigma-Aldrich). 
For live lung culture, slices were cultured in RPMI 1640 media in dou-
ble glass-bottomed plastic chambers (Thermo Fisher Scientific). Slic-
es were weighted with a steel washer overlying a tissue harp (Warner 
Instruments) and placed inside an environmentally controlled cham-
ber. After 1 hour equilibration, Alexa Fluor 647 anti-mouse CD31 anti-
body (102415, BioLegend) and Alexa Fluor 488 anti-mouse S100A9 
antibody (NBP2-47980AF488, Novus) were added directly to the 
media (38). Laser scanning confocal microscopy was performed using 
an inverted LSM 880 Airyscan Fast microscope (Carl Zeiss) and Airy-
scan processing was performed using default settings. Acquisition for 
both cultured and fixed slices used a Zeiss ×20 objective (0.8 NA, Plan 
Apochromat Air). During live lung imaging, preprogrammed automat-
ed time-lapse acquisition of cultured lung slices was used. Sequential 
alternating imaging of the control versus treated lung slice over the 
experiment approximated simultaneous recording. Z-stacks were 
acquired and projected using Imaris (Bitplane, Oxford Instruments) 
for analysis. For fixed slices, image stitching was performed using Zen 
black or blue software (Carl Zeiss) and represented an area of 1 mm × 1 
mm of tissue, imaged at 1 time point/position. Image analysis was per-
formed using IMARIS V 9.1 software (for examples of Imaris analysis, 
see Supplemental Videos 1 and 2).
Neutrophil chemotaxis and phagocytosis functional assays. Neutro-
phil chemotaxis to fMLF (0–100 nM) over 60 minutes was measured 
in the presence or absence of recombinant SEMA3F protein (10–100 
nM) (R&D Systems) using 5-μm filter NeuroProbe ChemoTx micro-
plates. For microfluidic chip assays, whole blood was applied to a sta-
ble LTB4 gradient (100 nM) and migration assessed using real-time 
light microscopy (21). To determine degree of phagocytosis, neutro-
phils were incubated with 0.2 mg/mL opsonized Zymosan A particles 
for 15 minutes at 37°C. Cytocentrifuge slides were then prepared and 
uptake of the yeast particles was assessed. The Phagocytic Index was 
calculated as follows: Phagocytic Index = (mean number of particles 
per neutrophil) × (percentage of neutrophils containing particles). 
Neutrophils were incubated with heat-inactivated fluorescein isothio-
cyanate–conjugated E. coli O55:B5 (Sigma-Aldrich) (MOI 1:1) for 30 
minutes at 37°C. Cells were washed with ice-cold PBS, resuspended 
in FACS buffer, and analyzed by flow cytometry (BD FACSCalibur, 
BD Biosciences, Becton Dickinson Ltd.). Data analysis was performed 
with FlowJo software (version 9.0, Tree Star Inc.).
Respiratory burst. Human neutrophils (1 × 106/mL) were cultured 
with recombinant SEMA3F protein (10 nM, 100 nM) (R&D Systems) 
for 1 hour before addition of 5 μM 2′7′-dichlorofluorescein diacetate 
(DCF) for 30 minutes. Cells were then stimulated with 100 nM fMLF 
for 30 minutes and FL1 geometric mean fluorescence was determined 
by flow cytometry.
F-actin quantification and distribution. Isolated peripheral blood 
neutrophils from healthy volunteers were incubated with recombinant 
SEMA3F (100 nM) and fMLF (100 nM). Neutrophils were fixed, per-
meabilized, stained with DAPI, and Alexa Fluor 488–conjugated phal-
loidin. Images were obtained using an Operetta High-Content Imaging 
System (Perkin Elmer) or LSM880 Airyscan Fast (Zeiss) and analysis of 
F-actin was performed by Harmony analysis software (Perkin Elmer).
Inflammation assay in zebrafish. Inflammatory responses were elic-
ited in zebrafish embryos by tail transection as previously described 
(8). Neutrophils were counted at the site of transection at 6 and 24 
hours after injury (hpi) using a fluorescence dissecting stereomicro-
scope (Leica Microsystems GmbH). Where possible, counting was 
performed blind to experimental conditions. For analysis of speed and 
meandering index of neutrophils toward the site of injury, embryos 
were mounted in 1% low melting point agarose (Sigma-Aldrich) con-
taining 0.017% tricaine, and tracked over 1 hour using a 1394ORCA-
ERA camera (Hamamatsu Photonics Inc.) on a TE2000-U Inverted 
Compound Fluorescence Microscope (Nikon). Tracking analysis was 
performed using Volocity 5 software (Improvision, Perkin Elmer).
Analysis of neutrophil polarity and roundness in neutrophils. Tg(-
lyz:PHAkt-EGFP)i277 larvae were injured 3 days after fertilization 
(dpf), mounted in 1% low melting point agarose (Sigma-Aldrich) con-
taining 0.017% tricaine, and imaged on an UltraVIEWVoX spinning 
disk confocal microscope (Perkin Elmer) with an inverted Olympus 
IX81 microscope. Neutrophils in the region between the site of inju-
ry and the posterior blood island were individually imaged in the 488 
nm laser line with 20 Z slices. Using Image J software, a transecting 
line was drawn from the trailing edge to the leading edge and a flu-
orescence intensity plot generated. Polarity index was calculated by 
(log10a/b) × ([a + b]/c), where a represents the mean fluorescence 
intensity of the trailing edge of the cell, b represents the mean fluo-
rescence intensity of the leading edge of the cell, and c represents the 
mean fluorescence intensity of the whole cell (20). In parallel, round-
ness was calculated using 4 × [area]/π × [major axis], where 0 rep-
resents a line and 1 a circle.
Animals. Mice were maintained in 12-hour-light/12-hour-dark 
cycles with free access to food and water. They were sex-, litter-, and 
age-matched into groups of 4 or 6 for experiments and then housed 
with their experimental littermates to avoid distress. Each mouse was 
given a numerical code and the genotype was revealed to the research-
er following data analysis. MRP8-driven Cre (Mrp8Cre) targeted 
Sema3f deletions to neutrophil populations. Sema3ffl/fl mice were gen-
erated via the Medical Research Council (MRC) International Mouse 
Phenotyping Consortium (SEMA3F_HEPD0570_6_A04, allele type 
Tm1c) with animals backcrossed to a C57BL/6 background (35–37). 
Catchup (IVM-RED Lifeact-GFP) mice were used for in vivo neutro-
phil imaging studies (21, 22). Rectal temperatures were acquired, and 
sickness scores were undertaken by blinded observers as follows: 0, 
normal health; 1, lethargy and ruffled fur; and 2, severe lethargy, ruf-
fled fur, and hunched back.
Intratracheal instillation of exogenous SEMA3F. Mice were anesthe-
tized with an intraperitoneal injection of medetomidine (1 mg/kg) and 
ketamine (76 mg/kg), and then instilled with 50 μL PBS or 1 μM SEMA3F 
via the trachea, followed by recovery with 1 mg/kg atipamezole.
Fixed and live murine lung slice imaging. After humane killing, the 
trachea was cannulated and instilled with 2% (wt/vol in PBS) low 
melting point agarose gel (Life Technologies). Lungs were dissected 
en bloc, washed in PBS, and placed in either methanol-free 4% form-
aldehyde solution in PBS (made by diluting 16% formaldehyde, vol/
vol; Thermo Fisher Scientific, Pierce, catalog 28908) for 2 hours (fixed 
lungs) or RPMI media (live lung culture), and 300 μm vibratome 
sections were generated (38). Fixed lung slices were incubated with 
unconjugated anti-S100A9 (HM1102, Hycult Biotech) and anti-
CD31 (ab119341, Abcam), and secondary staining performed using 
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LR, FVE, and PME interpreted the data. TP, SAR, AJWF, MKBW, and 
SRW designed the research and wrote the manuscript.
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